Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
4.020
-0.050 (-1.23%)
Sep 23, 2026, 9:53 AM EDT - Market open
Lexeo Therapeutics Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Lexeo Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $20.3. The average 1-year stock price forecast is 404.98% higher than the current stock price, while the lowest is $9.00 (+123.88%) and the highest is $30 (+646.27%).
Price Target: $20.3 (+404.98%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Aug 13, 2026.
Analyst Ratings
The average analyst rating for Lexeo Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 8 | 8 | 8 | 7 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 10 | 10 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $20 | Buy | Maintains | $20 | +397.51% | Aug 13, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $17 | Buy | Maintains | $17 | +322.89% | Jul 6, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $12 → $9 | Buy | Maintains | $12 → $9 | +123.88% | Jun 25, 2026 |
| Chardan Capital | Chardan Capital | Buy Reiterates $17 | Buy | Reiterates | $17 | +322.89% | May 11, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $20 | Buy | Reiterates | $20 | +397.51% | Mar 31, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.20
from -1.93
EPS Next Year
-1.37
from -1.20
EPS and Forward PE are based on non-GAAP adjusted numbers.